8-KLeadership ChangesExhibits & Filings

UNITEDHEALTH GROUP INC 8-K Report, Executive Changes (Feb 19, 2019)

Filed February 19, 2019For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) announced a significant addition to its Board of Directors with the election of John H. Noseworthy, M.D., effective immediately on February 12, 2019. Dr. Noseworthy brings extensive experience from his tenure as the former Chief Executive Officer and President of the Mayo Clinic, a highly respected global healthcare institution. His leadership background and deep understanding of complex healthcare operations are expected to be valuable assets to the UNH board as the company navigates the evolving healthcare landscape. This appointment signals a continued focus on strong governance and strategic oversight for UnitedHealth Group. Investors can view Dr. Noseworthy's credentials, which include roles on various boards and advisory groups within the healthcare and pharmaceutical sectors, as a positive indicator of the company's commitment to bringing in seasoned leadership. He will be compensated according to the company's standard director compensation program and will receive the company's standard indemnification agreement.

Key Highlights

  • 1UnitedHealth Group elected Dr. John H. Noseworthy, former CEO of Mayo Clinic, as an independent director, effective February 12, 2019.
  • 2Dr. Noseworthy's background includes 28 years at Mayo Clinic in various leadership and academic roles, including CEO and President.
  • 3His extensive experience is expected to enhance the strategic oversight and governance of the UNH Board of Directors.
  • 4Dr. Noseworthy currently serves as a director for Merck & Co.
  • 5He previously served as a Health Governor for the World Economic Forum.
  • 6Dr. Noseworthy will receive standard compensation for non-employee directors and enter into the company's standard indemnification agreement.
  • 7There are no disclosed arrangements or material interests between Dr. Noseworthy and the company that would require further disclosure.

Frequently Asked Questions

Dr. John H. Noseworthy is the former Chief Executive Officer and President of the Mayo Clinic, a renowned healthcare organization. His election as an independent director to the UnitedHealth Group Board brings significant leadership experience in the healthcare sector, which is expected to strengthen the company's governance and strategic direction.

Dr. Noseworthy will be compensated in accordance with UnitedHealth Group's standard compensation program for non-employee directors. Specific details of this program are outlined in Exhibit 10.26 of the company's Annual Report on Form 10-K for the year ended December 31, 2018.

Based on the filing, there are no disclosed arrangements or understandings between Dr. Noseworthy and any other person related to his appointment. Furthermore, he has no direct or indirect material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K. He does, however, currently serve as a director of Merck & Co.

Dr. Noseworthy's extensive leadership at the Mayo Clinic, a top-ranked healthcare provider, demonstrates his deep understanding of complex healthcare systems, patient care, and operational management. His involvement with the World Economic Forum as a Health Governor indicates a broader perspective on global health trends and policy. These experiences are valuable for UnitedHealth Group's strategic planning and oversight.